SIGN UP

October 25, 2024 10:36 AM EDT

EnGene’s $60M PIPE; AbbVie to develop neuropsychiatric drugs with Gedeon Richter

ENDPOINTS

Plus, news about Tectonic Therapeutic, Molecular Partners and Arcus Biosciences:

EnGene snags $60M: The Boston and Montreal gene therapy biotech

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

sponsored

Are programs with compounded GLP-1s safe for your population?